More than 15,000 young people aged out of foster care in FY2025 — leaving the system without a permanent family and, in many cases, without the tools to...
More than four years into Russia's full-scale invasion of Ukraine, the Congressional Research Service is putting Congress on notice: the diplomatic path to...
As the Trump administration pursues sweeping cuts to federal spending, a newly updated Congressional Research Service report offers a detailed look at how...
The House Veterans' Affairs Committee convened on May 20 to consider one of the most expansive VA reform packages in recent memory, advancing 23 bills and...
Why it matters: The Senate Small Business and Entrepreneurship Committee held a hearing on May 20, 2026 focused on government fraud and the retaliation...
Florida's top emergency official is heading into the 2026 hurricane season with cautious optimism about FEMA funding Florida has long struggled to access...
San Francisco-based Apogee Therapeutics (Nasdaq: APGE) has announced a strategic financing collaboration with funds managed by Blackstone Life Sciences,...
LifeArc backs Elpida Therapeutics gene therapy push for three ultra-rare childhood diseases
A Congressional Research Service report updated May 14 finds that the federal government has only partially implemented a 2021 law designed to build a...
A new Congressional Research Service report on wildfire fuel treatments lands at a politically charged moment: the Trump Administration is simultaneously...
A new Congressional Research Service report is putting military infertility benefits back on the legislative agenda, documenting a persistent gap between...
A quiet but consequential shift in how the federal government publishes scientific research is on a collision course with fiscal reality. The U.S....
The House Foreign Affairs Committee convened May 20 to examine the FY2027 budget requests for what the committee termed "State Department Adjacent...
A new Congressional Research Service report on federal funding gaps documents what is now the most chaotic appropriations year in modern U.S. history, and...
Reprogram Biosciences, a preclinical oncology company based in San Carlos, California, has closed a seed financing round that brings total capital raised to...
Waltham, Massachusetts-based Q32 Bio Inc. (Nasdaq: QTTB) announced a USD 55 million private placement of common stock and pre-funded warrants to fund the...
Roche has received the first clinical milestone under its global exclusive licensing agreement with Qyuns Therapeutics (HKEX: 2509), triggered by the dosing...
XtalPi Holdings (HKEX: 2228) has received a second payment of USD 19 million from DoveTree under their AI-driven drug discovery collaboration, bringing...
The Trump Administration's proposed FY2027 budget appropriations for U.S. diplomacy and foreign assistance would cut Department of State funding by nearly...
D&D Pharmatech (Kosdaq: 347850) has reported 48-week histology data from its Phase II trial of zabopegdutide in metabolic dysfunction-associated...
Precision BioSciences (Nasdaq: DTIL) reported the first clinical evidence of direct cccDNA elimination in liver biopsies from patients with chronic...
NEOK Bio doses first patients in Phase I trials of dual bispecific ADCs targeting B7-H3/ROR1 and EGFR/MUC1
Sobi (STO: SOBI) has reported that olezarsen (Tryngolza) reduced the relative risk of acute pancreatitis by 85% and lowered triglycerides by 66% in a pooled...
